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Summary. It has been commonly supposed that adult
stem cells co-localize with supporting cells within
specific regions or specialized microenvironment in each
tissue/organ, called stem cell niche. This concept was
based on the assumption that stem cells are intrinsically
hierarchical in nature. However, recent data indicate that
stem cells may represent a continuum with reversible
alterations in phenotype taking place during the transit
through cell cycle. Based on this dynamic interpretation
it has been suggested that the so-called niche is
represented by a single or only few cell types continually
adjusting their phenotype and function to individual
circumstances. A critical component in the regulation of
the continuum of stem cell phenotypes is the
microenvironment. In this context, microvesicles (MVs)
account for the transfer of genetic information between
cells. Originally considered inert cellular debris, MVs
are increasingly recognized to be important mediators of
cell-to-cell communication. MVs may transfer receptors,
proteins, mRNA and microRNA to target cells via
specific receptor-mediated interaction. In stem cell
biology the exchange of genetic information may be
bidirectional from stromal to stem cells. In the context of
tissue injury the MV-mediated transfer of genetic
information may reprogram the phenotype of stem cells
to acquire features of the injured tissue cells. In addition,
MVs derived from stem cells may induce de-
differentiation of cells which have survived injury with a
cell cycle re-entry that may allow tissue regeneration. In
the present review we discuss the possibility of a
continuous genetic modulation of stem cells by a MV-
mediated transfer of information between cells. 
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Introduction 
Stem cells are a subset of cells capable of unlimited
self renewal and of high multilineage differentiation
potential into different types of mature cells. Based on
these characteristics, stem cells play essential roles in
organogenesis during embryonic development, and in
the adult are responsible for the growth, homeostasis and
repair of many tissues. 
Stem cells may be classified according to their origin
and developmental status in embryonic and adult stem
cells. The embryonic stem cells (ESC) are derived from
the inner cell mass of the blastocyst-stage mammalian
embryo a few days after fertilization and they are
pluripotent, giving rise to the germ line during
development and to virtually all tissues of the organism. 
In contrast to ESC, the stem cells present in the adult
organism (tissue-resident adult stem cells) are
undifferentiated cells localized in differentiated tissues,
with a more limited self renewal and differentiation
potential, usually restricted to cell types of the tissue
from which they originate. The adult stem cells are
involved in tissue homeostasis and repair after wounding
over the lifetime. Many studies indicate that in
pathological conditions adult stem cells can actively
participate in tissue cell replenishment after being in a
quiescent state for short or long periods of time (Bryder
et al., 2006; Mimeault and Batra, 2006; Mimeault et al.,
2007) These cells when partially committed to
differentiate in a defined lineage are also named
progenitor cells. Adult stem/progenitor cells have been
identified in most tissues and organs of mammalian
organisms, such as bone marrow, liver, pancreas, heart,
kidney, brain, lung, digestive tract, retina, breast,
ovaries, prostate, testis, dental pulp, hair follicles, skin,
skeletal muscle, adipose tissue and blood (Mimeault and
Batra, 2008). 
In tissues that require a high cell turnover, such as
the hematopoietic system, the intestine and the skin,
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stem cells are critical for maintaining their homeostasis.
In other tissues with a much lower rate of cell turnover,
such as the kidney, the lung, skeletal muscle and the
liver, resident stem cells may awake following injury
and participate in tissue repair. 
The most common source of adult stem cells is the
bone marrow, where there are two main stem cell
populations: the hematopoietic stem cells (HSC),
committed to differentiate into fully specialized cells of
the blood (erythrocytes, thrombocytes and leukocytes),
and the mesenchymal stem cells (MSC), undifferentiated
adult stem cells of mesodermal origin that have the
capacity to differentiate into cells of connective tissue
lineages, including bone, fat, cartilage and muscle (Jiang
et al., 2002). Moreover, resident adult stem cells have
been isolated from several tissues, including the central
nervous system (Reynolds and Weiss, 1992), retina
(Tropepe et al., 2000), skeletal muscle (Jackson et al.,
1999), liver (Herrera et al., 2006) and kidney (Bussolati
et al., 2005). 
Tissue resident stem cells preferentially generate
differentiated cells of the tissue of origin, suggesting a
relevant role in the postnatal growth of organs, in
physiological turnover and in tissue repair. 
The stem cell niche
It has been generally reported that tissue-resident
adult stem cells are co-localized with supporting cells
within specific regions or specialized micro-
environments in each tissue/organ, called stem cell niche
(Li and Xie, 2005; Moore and Lemischka, 2006; Jones
and Wagers, 2008). In adult bone marrow the HSC could
reside in the endosteal niche, associated with the
osteoblasts of the inner surface of the cavities of
trabecular bone that could provide factors able to
regulate number and function of HSC through the
secretion of osteopontin, and a complex and not
completely identified paracrine signalling network i.e.
Kit/Kit ligand, Notch signaling, angiopoietin-1/Tie-2
(Mitsiadis et al., 2007). Functional regulation of HSC
may occur at the endosteal niche through the activation
of osteoclasts by RANKL, produced by osteoblasts and
mobilization of HSC into the circulation (Kollet et al.,
2006). Another niche for HSC is the perivascular area of
sinusoids that could provide homeostatic blood cell
production and response to hematological stresses (Kiel
et al., 2005). The perivascular niche is possibly the main
site of stem cells in organs that do not contain bone, such
as liver and spleen (Mitsiadis et al., 2007). Even in bone
marrow it is considered that two thirds of HSC are
localized in perivascular areas (Crisan et al., 2008; da
Silva Meirelles et al., 2008; Caplan, 2009). The
fenestrations of bone marrow sinusoids and the
expression by the endothelial cells of chemokines and
adhesion molecules such as E-selectin and VCAM-1,
may be critical for HSC homing and mobilization
(Sipkins et al., 2005; Wilson and Trumpp, 2006). The
two niches could be functionally distinct: the endosteal
niche could maintain HSC quiescence over the long
term, whereas the perivascular niche could maintain
HSC over a shorter time period, supporting HSC
proliferation, favouring myeloid and megakaryocytic
lineage differentiation and mediating HSC entry into
circulation (Mitsiadis et al., 2007; Perry and Li, 2007).
The other stem cells present in bone marrow are MSC,
which play a role in providing stromal support for HSC
in the bone marrow (Noort et al., 2002). MSC localize in
perivascular areas in the bone marrow in close
association with HSC (Shi and Gronthos, 2003) and
could play a role in maintaining quiescence of HSC by
inhibiting their proliferation and differentiation (Glennie
et al., 2005). 
In search of a tissue resident stem cell niche
Many studies reported the presence of other stem
cell niches in mammals (Li and Xie, 2005; Da Silva
Meirelles et al., 2008): the epithelial stem cell niche in
skin resides in the bulge area of the hair follicle beneath
the sebaceus gland (Cotsarelis et al., 1990; Sun et al.,
1991; Niemann and Watt, 2002); the intestinal stem cell
niche, where stem cells are located at the fourth or fifth
position above the Paneth cells from the crypt bottom
(Booth and Potten, 2000; He et al., 2004; Sancho et al.,
2004); finally, the neural stem cell niche at the
subventricular zone and the subgranular zone of the
hippocampus where neural stem cells could reside and
support neurogenesis in the adult brain (Doetsch et al.,
1999; Temple, 2001). 
Several studies suggest that the adult tissue resident
stem cells belong to the MSC lineage (da Silva Meirelles
et al., 2006). However, MSC derived from different
organs are defined mainly by functional in vitro assays
using cultured cells, and their in vivo exact localization
and function remain elusive (da Silva Meizelles et al.,
2008). 
The Mesenchymal and Tissue Stem Cell Committee
of the International Society for Cellular Therapy
proposed the minimal criteria to define human MSC
(Dominici et al., 2006; Da Silva Meirelles et al., 2008),
which include cell positivity for CD105, CD73, and
CD90 and negativity for CD45, CD34, CD14 or CD11b,
CD79a or CD19, and HLA-DR. However, a specific
identification marker for isolation of MSC or their
identification in tissues is still lacking. Stro-1 marker is
not exclusively expressed by MSC and may be lost
during culture (Kolf et al., 2007). Recent studies have
shown that stage-specific embryonic antigen 1 (SSEA-1)
and SSEA-4 are expressed by human bone marrow MSC
(Anjos-Afonso and Bonnet, 2007; Gang et al., 2007).
Moreover, CD200 has been suggested as a marker useful
for the purification of bone marrow MSC, although it is
also expressed by thymocytes, B and T lymphocytes,
and endothelial cells (Wright et al., 2001), if used in
combination with other MSC markers. The minimal
criteria to define human MSC include also osteo-,
chondro-, and adipogenic differentiation capabilities.
398
Microvesicles convey genetic information
However, in vitro results have not allowed much insight
into the recognition of these cells in organs. Two
different possibilities are considered to date. First, the
possibility that MSC are only located in the bone
marrow, from which they may circulate to other tissues
to replenish losses of cell population following
physiological turnover or tissue injury. Against this
hypothesis stands the considerable difficulty in
establishing MSC cultures from peripheral blood
(Wexler et al 2003; da Silva Meirelles et al., 2006). As
an alternative, the possibility that different tissue-
intrinsic stem cells might behave in vitro as MSC since
MSC have been isolated from virtually all different
tissues with very similar morphologic, immuno-
phenotypic, and functional properties (da Silva Meirelles
et al., 2006). In this context, a perivascular location for
MSC has been suggested, correlating these cells with
pericytes that would adequately explain why MSC can
be isolated from all tissues. The establishment of MSC-
like cultures from isolated blood vessels, including
decapsulated glomeruli (da Silva Meirelles et al., 2006),
argues in favour of this hypothesis. In this model the
perivascular zone may act as a MSC niche in vivo, where
microenvironment factors may modulate their phenotype
with transition to progenitor and mature cells. 
Stem cell niche or area of influence? 
For many years it has been assumed that the
regulation of bone marrow stem cells was intrinsically
hierarchical in nature with a progressive loss of
proliferative potential and expression of differentiated
phenotypes (Till et al., 1964). More recently, a
continuum model of stem cell biology has been proposed
(Colvin et al., 2004; Quesenberry et al., 2005). On the
basis of the well-known stem cell plasticity, stem cells
represent a very heterogeneous population. It has been
postulated that the phenotype of bone marrow stem cells
is labile, it varies with position in the cell cycle and that
it is reversible (Fig. 1). Therefore, bone marrow stem
cells may be defined not at a single cell level, because
the single cell phenotype and functional potential
continually and reversibly change, but rather on a
population basis (Colvin et al., 2007). This cell-cycle
reversibility of hematopoietic and non hematopoietic
cells is at the basis of the continuum model of stem cell
biology, in which the phenotype of stem cells is
reversibly changing during the cell cycle transit until a
terminal-differentiating stimulus is encountered at a
cycle-susceptible time (Colvin et al., 2007). In this
model the status of the cell cycle and the exposure to
products from injured cells may play key roles in
determining the differentiated expression of a bone
marrow stem cell. The same stem cell may show
different phenotypes in different functional states,
possibly tied up to cell cycle phase (Quesenberry et al.,
2007 ). Recently, Quesenberry and Aliotta (2008)
proposed the existence not simply of several unique
niche cells, but of a variety of niche cells which
continually change phenotype to appropriately interact
with the continuum of stem cell phenotypes. Since bone
marrow stem cells continually change their phenotype
and are very heterogeneous, there exist innumerable
different niche cells. These Authors are doubtful that the
so-called niche is represented by a single or only a few
cell types, and prefer to designate the bone marrow
microenvironment as consisting of areas of influence
which are continually adjusting to individual
circumstances (Quesenberry and Aliotta, 2008). This
concept may possibly be extended to tissue resident stem
cells. 
Stem cell plasticity and microenvironment
interactions 
Several studies have confirmed the plasticity of bone
marrow stem cells leading to differentiation in non-
hematopoietic cells, although it is not clear whether
transdifferentiation, dedifferentiation or fusion occur
(Quesenberry et al., 2007). Endogenous bone marrow-
derived stem cells have been reported to contribute to
the repair of tissue injury. Some reports indicate that
bone marrow derived stem cells are capable of
engraftment into damaged tissues, although the lineage
of stem cells recruited has not been definitively
established. Based on bone marrow transplantation in
mouse Fang et al. (2008) demonstrated that bone
marrow derived cells contribute to the repair of acute
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Fig. 1. Schematic representation of the Continuum model of stem cell
differentiation. In this model the phenotype of stem cells is reversibly
changing during the cell cycle transit until a terminal-differentiating
stimulus is encountered (Quesenberry et al., 2007). The stem cell
phenotype is very flexible, depending on cell cycle phase and specific
microenvironment and could characterize the same cell in different
functional states or phases of cell cycle.
renal injury and suggested that the HSC rather than the
MSC are involved. 
However, this issue remains highly controversial and
several studies point to a paracrine/endocrine action of
endogenous stem cells rather than of a direct
repopulation of the injured tissues (Humphreys and
Bonventre, 2008). Experiments with exogenous MSC
administration in AKI demonstrate a functional and
morphologic recovery associated only with a transient
recruitment of MSC within the renal vasculature with a
minimal incorporation within the regenerating tubules
(Duffield et al., 2005; Tögel et al., 2005). It has been
suggested that the transient presence of the MSC within
the injured tissues may provide a paracrine support to
the repair, which is mainly sustained by intrinsic
epithelial cells which survived injury. (Humphreys et al.,
2008) Indeed, there is a growing body of evidence
supporting the hypothesis that paracrine/
endocrine mechanisms mediated by factors released by
the bone marrow-derived stem cells play an essential
role in the repair observed after stem cell mobilization or
injection into injured kidney or infarcted hearts (Gnecchi
et al., 2008). 
Strong support of a paracrine/endocrine mechanism
for tissue repair comes from experiments of
administration of conditioned medium from MSC, which
was found to be able to mimic the beneficial effects of
stem cell therapy. Bi et al. (2007) showed that MSC may
protect kidney from toxic injury independently from
their tubular engraftment, by producing factors that limit
apoptosis and enhance proliferation of tubular cells.
Similar results were obtained for the beneficial effect of
stem cells in myocardial injury (Gnecchi et al., 2008).
The frequency of stem cell engraftment and the number
of newly generated cardiomyocytes and vascular cells,
either by transdifferentiation or cell fusion, appear too
low to explain the beneficial effects observed (Gnecchi
et al., 2008). On the other hand several studies indicate
that stem cell released soluble factors may contribute to
cardiac repair and regeneration (Caplan and Dennis,
2006). One can also postulate that paracrine factors may
mediate endogenous regeneration via activation of
resident cardiac or kidney stem cells. Therefore, a
dynamic regulation and interaction of stem cell derived
factors that influence cell survival and tissue
regeneration can be proposed, involving the activation of
resident and circulating stem cells. Specific studies will
need to define the factors and the pathways involved, as
well as their temporal and spatial expression in the
injured tissues (Gnecchi et al., 2008). A comprehensive
characterization of the paracrine factors and their
pathways will allow a better understanding of stem cell
biology and the identification of new therapeutic
strategies. 
Besides soluble factors, microvesicles (MVs) have
been described as a new mechanism of cell to cell
communication, potentially involved in the stem cell
biological actions (Morel et al., 2004; Ratajczak et al.,
2006a). 
Role of microvesicles in cell to cell communication 
MVs are derived from the endosomal membrane
compartment after fusion with the plasma membrane and
are released from the cell surface of activated cells
(Heijnen et al., 1999; Rozmyslowicz et al., 2003). MVs
are shed by various cell types, such as circulating blood
cells and cells of the vessel wall during cell activation by
agonists and physical or chemical stress. In vivo, the
majority of MVs are derived from platelets (George et
al., 1982), and to a lesser extent from other blood cells
and endothelial cells (Martinez et al., 2005). MVs
represent a heterogeneous population, differing in
cellular origin, number, size and antigenic composition
(Diamant et al., 2004). MVs were originally considered
to be inert cellular debris. It is now recognized that MVs
may interact with cells through specific receptor-ligand
interactions, leading to target cell stimulation directly or
by transferring surface receptors (Janowska-Wieczorek
et al., 2001; Morel et al., 2004). MVs derived from
activated platelets are able to induce metastasis and
angiogenesis in lung cancer (Janowska-Wieczorek et al
2005). Moreover, tumor-derived MVs may transfer
surface determinants and mRNA of tumor cells to
monocytes (Baj-Krzyworzeka et al., 2006). It has been
also postulated that MVs may contribute in spreading
certain infective agents, such as HIV or prions (Facler
and Peterlin, 2000; Fevrier et al., 2004). 
The recent finding that MVs may shuttle selected
patterns of mRNA and of microRNA suggests that MVs
may represent a new mechanism of genetic exchange
between cells (Ratajczak et al., 2006b; Deregibus et al.,
2007; Dooner et al., 2008a; Yuan et al., 2009). 
We demonstrated that MVs are vehicles for mRNA
transport and exchange of genetic code between cells.
MVs generated from endothelial progenitor cells (EPC)
are incorporated in normal endothelial cells by
interaction with α4- and ß1-integrins expressed on their
surface (Deregibus et al., 2007). Once incorporated,
MVs activate an angiogenic program in the endothelial
cells by promoting cell survival, proliferation and
organization in vitro in capillary-like structures. In vivo,
in SCID mice, MVs stimulate human endothelial cells to
organize in a patent vessel network connected with the
murine vasculature. When MVs are pretreated with
RNase, they lose the angiogenic activity even though
they are internalized by endothelial cells. This suggests
that the angiogenic effect of MVs is related to transfer of
RNA following MV incorporation within the endothelial
cells. The microarray analysis and the quantitative RT-
PCR of MV-mRNA extract indicate that MVs derived
from EPC are shuttling a specific subset of cellular
mRNA, such as mRNA associated with the PI3K/AKT
and eNOS signalling pathway. Protein expression and
functional studies demonstrated that PI3K and eNOS
play a critical role in the angiogenic effect of MVs. As
proof of the effective transfer of mRNA, green
fluorescence protein (GFP) can be transduced in target
endothelial cells by MVs carrying GFP mRNA
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(Deregibus et al., 2007). Besides mRNA, MVs may
transfer in target cells microRNA, as recently shown for
ESC-derived MVs (Yuan et al., 2009). Indeed, the ESC
represent an abundant source of MVs and it has been
suggested that MVs derived from these cells may
represent one of the critical components supporting self
renewal and expansion of stem cells (Ratajczak et al.,
2006a,b). Moreover, Ratajczak et al. (2006b)
demonstrated that ESC-derived MVs are able to
reprogram hematopoietic progenitors by a horizontal
transfer of mRNA and protein delivery. Taken together
these results indicate that MVs may be important
paracrine mediators of signaling within stem cells and
differentiated cells by transferring selected patterns of
proteins, mRNA and microRNA.
Role of MVs derived from injured tissue in inducing
change in the phenotype of bone marrow stem cells 
The evidence that MVs may act as paracrine
mediators raises the question as to whether they could be
involved in injured tissue-induced change in the
phenotype of stem cells. Several studies indicate that
bone marrow derived stem cells may contribute to tissue
repair. It has now been established that bone marrow
cells, probably the HSC which are mobilized in higher
numbers than MSC, have the capacity to produce non-
marrow cells in many injured tissues after engraftment
(Quesenberry et al., 2007, Dooner et al., 2008b). The
underlining mechanism leading to stem cell
activation/differentiation after interaction with injured
cells remains to be defined. Transdifferentiation as a
mechanism of stem cell plasticity is highly unlikely,
since it has never been conclusively demonstrated in any
experimental setting (Quesenberry et al., 2007). Fusion
appears to be a mechanism of marrow plasticity in some
reports but not in others (Jang et al., 2004a; Rovó and
Gratwohl, 2008; Colletti et al., 2009). In lung injury, cell
fusion has been evaluated in cross-sex transplantation
experiments but did not explain the lung differentiation
of bone marrow-derived stem cells (Harris et al., 2004).
On the other hand, differentiation from a rare population
of resident stem cells has never been excluded.
Epigenetic cell changes mediated by signals received
from injured cells are possibly involved in stem cell
differentiation. Quesenberry et al. (2008) suggested that
differentiation in response to specific signals, especially
from injured cells, may be delivered in unique fashion
by MV-mediated transfer of genetic information (Fig.
2A). Jang and Sharkis (2004b) demonstrated in co-
culture experiments of bone marrow cells, separated
from injured liver cells by a cell impermeable
membrane, that bone marrow cells express the albumin
gene and the protein. Dooner et al. (2008a), in a similar
experimental setting, demonstrated that murine bone
marrow cells express genes for lung-specific proteins
such as Clara cell-specific protein, surfactant B, and
surfactant C. Moreover, they found that the injured lung
conditioned medium also induced lung-specific gene
expression in bone marrow cells and that this activity
resided in MVs released in the cell supernatant. These
MVs were shown to contain high levels of lung-specific
mRNA and to deliver this mRNA to bone marrow cells,
suggesting that MV derived from injured tissue might
mediate bone marrow cell phenotype change during
physiologic tissue repair.
Regenerative potential of microvesicles
On the other hand, MVs released from stem cells
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Fig. 2. Schematic
representation of MV-
mediated mechanism
of tissue repair. The
MV-mediated
exchange of genetic
information may be
bidirectional. A. MVs
derived from injured
cells may transfer to
stem cells specific
subsets of mRNA and
microRNA that induce
a stem cell
differentiation with a
contribution to the
repair of the injured
tissue. B. MV-
mediated transfer of
mRNA, micro RNA or
proteins from bone
marrow-derived or tissue resident stem cells may reprogram the phenotype of mature cells by inducing de-differentiation of cells which survived injury
and their re-entry into the cell cycle, with repopulation of the injured tissue and re-differentiation into mature tissue cells. Inset: micrograph of
transmission electron microscopy of MVs released from human MSC. The image shows small vesicles of approximately 120 nm in diameter. (Modified
from Camussi et al. (2009). 
recruited at the site of tissue injury may induce de-
differentiation of resident cells which survived injury,
making them transiently acquire a stem cell-like
phenotype with the activation of tissue regenerative
programs (Fig. 2B). In this context one can interpret the
MV-induced activation of a pro-angiogenic program in
endothelial cells (Deregibus et al., 2007). Moreover, we
recently demonstrated that MVs derived from human
MSC are able to stimulate in vitro proliferation and
apoptosis resistance of tubular epithelial cells (Bruno et
al., 2009). When administered in vivo in SCID mice with
acute kidney injury MVs accelerate the functional and
morphological recovery. The beneficial effect of MV
administration is comparable to that of human bone
marrow-derived MSC. Also, in this experimental setting
RNase treatment of MVs abrogate both the in vitro and
the in vivo effects of MVs, suggesting that mRNA
shuttled by MVs is the final effector of their biological
activity. Differently from MVs derived from EPC, where
we identified mRNA for defined signal transduction
pathways, MVs released by MSC contain mRNA
representative of the multiple differentiative and
functional properties of MSC, indicating a cell
specificity of the mRNA content. The effective
horizontal transfer of mRNA is indicated by the presence
of human specific mRNA and proteins in tubular cells of
mice with acute kidney injury treated with MVs derived
from human MSC. 
The mechanisms involved in tissue regeneration
induced by the administration of exogenous stem cells
are still unclear. Our own bias is toward an MV-
mediated transfer of mRNA/proteins derived from stem
cells that may induce de-differentiation of mature cells,
triggering a proliferative program that may contribute to
the repair of tissue injury. 
These studies open new research perspectives on the
use of MVs to transfer RNA-based information from
stem cells/precursors to injured cells as a potential
therapeutic strategy. An advantage of using MVs in
regenerative medicine instead of stem cells is to avoid
the possible maldifferentiation of engrafted cells that
may occur in the long term (Kunter et al., 2007).
Conclusion
Recent work by several groups has suggested a basic
mechanism for cell plasticity based on the exchange of
genetic material, which may involve either
differentiation of stem cells or de-differentiation of
mature cells. This mechanism might underlie the
observed functional changes in target cells and
corroborate the continuum theory of stem cell biology.
According to this theory the stem cells continuously and
reversibly change their phenotype on a cell cycle–related
manner. This would imply that various stem cell types
may be simply functional variants of one another.
Studies showing that MVs mediate transfer of
genetic information suggest a unique mechanism for the
plasticity that could explain the observed plasticity of
stem cells and also the functional effects without the
need of transdifferentiation into tissue cells. The MV-
mediated transfer of genetic information mimics a mini-
cell fusion with deep effects on the phenotype of stem
cells (Quesenberry and Aliotta, 2008). On the other
hand, MVs derived from stem cells may re-direct altered
functions in target cells, suggesting that they could be
exploited in regenerative medicine to repair damaged
tissues (Camussi et al., 2009). 
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